2017
DOI: 10.1155/2017/6027305
|View full text |Cite
|
Sign up to set email alerts
|

Inflammation, Immunity, and Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
124
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 159 publications
(140 citation statements)
references
References 0 publications
1
124
0
Order By: Relevance
“…Chronic inflammation is involved in the development of a wide variety of tumors. 15 , 16 In cervical cancer patients, IL-6 and IL-8 concentrations in cervicovaginal washings are significantly higher than those in cervical intraepithelial neoplasia patients and controls. 17 19 In most patients, local IL-6 and IL-8 levels were also higher in serum.…”
Section: Introductionmentioning
confidence: 93%
“…Chronic inflammation is involved in the development of a wide variety of tumors. 15 , 16 In cervical cancer patients, IL-6 and IL-8 concentrations in cervicovaginal washings are significantly higher than those in cervical intraepithelial neoplasia patients and controls. 17 19 In most patients, local IL-6 and IL-8 levels were also higher in serum.…”
Section: Introductionmentioning
confidence: 93%
“…Cancer-associated inflammation involves crosstalk between malignant and non-malignant cells in an autocrine and paracrine fashion through mediators such as cytokines, chemokines and prostaglandins [21]. With the combined force of genetic alteration, inflammatory tumor microenvironments contribute towards tumor growth and distant metastasis [22]. Furthermore, the carcinogenic effect of inflammatory response could be inhibited by using anti-inflammatory drugs [23].…”
Section: Vcna Cav1 Epcam Egf Gpc3 Col1a1 Timp1 Ccl5 Csf1r DCmentioning
confidence: 99%
“…In addition, it predicts response to immune checkpoint blockade in human melanoma [33]. Together with genetic alterations, the inflammatory tumor environment leads to progression and metastasis of tumors eventually [34]. A3G in SKCM regulates a range of inflammation-related signaling pathways such as TNF-α signaling via the NF-κB pathway, IL2-STAT5 signaling, IL6/JAK-STAT3 signaling.…”
Section: Discussionmentioning
confidence: 99%